Gender Difference in sidE eFfects of ImmuNotherapy: a Possible Clue to Optimize cancEr tReatment
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Melanoma|Lung Cancer|Head and Neck Cancer|Urogenital Neoplasms|Breast Cancer
Interventions: DRUG: Immunotherapy
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Collaborators: Karolinska University Hospital|St Vincent's University Hospital, Ireland|Oslo University Hospital